- Home
- GTBP vs LCFY Comparison
GTBP vs LCFY Comparison
Compare GTBP & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTBP | LCFY |
|---|---|---|
| Founded | 1965 | 2009 |
| Country | United States | Australia |
| Employees | N/A | 18 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 8.3M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | GTBP | LCFY |
|---|---|---|
| Price | $0.44 | $3.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 13.7K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $2.50 |
| 52 Week High | $3.73 | $13.98 |
Technical Indicators
Market Signals| Indicator | GTBP | LCFY |
|---|---|---|
| Relative Strength Index (RSI) | 52.77 | 33.80 |
| Support Level | $0.39 | $3.14 |
| Resistance Level | $0.46 | $4.86 |
| Average True Range (ATR) | 0.05 | 0.20 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 57.23 | 0.00 |
Price Performance
Historical ComparisonAbout GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
About LCFY Locafy Limited
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.